Paper Review Records
全部论文审稿周期
1 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
74
天
Sanguinarine Suppresses Lung Adenocarcinoma via TGF-β1/Smad3 Path way: Insights from Network Analysis and Experimental Validation
作者
Rong Yuan; Xiaona Li; Junqi Wang; Zhaojun Xu; Lan Song展开收起
作者单位
1. Medicine School, Hunan University of Chinese Medicine, 300 Xueshi Road, Hanpu Science and Teaching Park, Changsha, Hunan, 410208 , China ;; 2. Hunan Provincial Key Laboratory of Vascular Biology and Translational Medicine, 300 Xueshi Road, Hanpu Science and Teaching Park, Changsha, Hunan, 410208 , China ;; 3. Hebei Yuzhilin Biotechnology Co., Ltd., No. 168 Haidian Road, Shijiazhuang, Hebei, 050035 , China ;; 4. Cardiothoracic Surgery of the First Affiliated Hospital, Hunan University of Chinese Medicine, 97 Shaoshan Road, Changsha, Hunan, 410007 , China展开收起
FAQ
CURRENT PHARMACEUTICAL DESIGN审稿要多久?
截至2026-11-19,CrushSCI 只收录了 CURRENT PHARMACEUTICAL DESIGN 的 1 篇完整审稿记录:Sanguinarine Suppresses Lung Adenocarcinoma via TGF-β1/Smad3 Path way: Insights from Network Analysis and Experimental Validation,2025-05-15 收稿,2025-07-28 录用,审稿 74 天。只有一篇样本,结果仅供参考。
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
